Triglycerides: The Metabolic Marker Most People Ignore
July 15, 20252 min read
Triglycerides are a more actionable cardiovascular risk marker than LDL for many people — they respond dramatically to dietary changes, omega-3 supplementation, exercise, and metabolic interventions, often improving 30-50% within weeks.
Why Triglycerides Matter
Elevated triglycerides (above 150 mg/dL) are an independent cardiovascular risk factor and a marker of metabolic dysfunction — specifically insulin resistance, excess carbohydrate intake, and impaired fatty acid metabolism. The triglyceride-to-HDL ratio is one of the best available proxies for insulin resistance: a ratio above 3.5 suggests the metabolic syndrome pattern of small dense LDL that drives atherosclerosis regardless of total LDL-C levels.
Evidence-Based Triglyceride Reduction
Omega-3 (EPA+DHA): The most potent nutritional triglyceride-lowering intervention. At 2-4g daily, omega-3s reduce triglycerides by 15-30% through decreased hepatic VLDL production and increased lipoprotein lipase activity. The FDA has approved prescription omega-3 (Vascepa, Lovaza) specifically for hypertriglyceridemia, validating the mechanism. Omega-3 Fish Oil provides therapeutic-quality EPA and DHA. Berberine: Reduces triglycerides through AMPK-mediated increases in fatty acid oxidation and decreased de novo lipogenesis. Berbercol. Dietary carbohydrate reduction: Triglycerides respond most dramatically to reducing refined carbohydrates and added sugars — often dropping 30-50% within 2-4 weeks of significant carb reduction.
Triglycerides are one of the most responsive metabolic markers. Dietary changes (reducing refined carbs and sugar) can produce 30-50% reductions within 2-4 weeks. Omega-3 supplementation shows measurable improvement within 4-8 weeks. Berberine effects build over 8-12 weeks.
What triglyceride level should I target?
Optimal is below 100 mg/dL. Below 150 is considered normal. Above 200 is high, and above 500 requires medical intervention due to pancreatitis risk. The triglyceride-to-HDL ratio (ideally below 2.0) may be more predictive of cardiovascular risk than triglycerides alone.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
